arrow
L

Louise Izatt

guy's and st thomas' nhs foundation trust
H指数:53
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OC7.6 - ECE_2870 - SOX2-positive cells in pheochromocytoma and paraganglioma: implications for tumour initiation and maintenance

OC7.6 - ECE_2870 - SOX2阳性细胞在嗜铬细胞瘤和副神经节瘤中的作用:对肿瘤起始和维持的启示

2026-08-100
OAAI
Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+stem cells

嗜铬细胞瘤和副神经节瘤含有肿瘤起始的SOX2阳性干细胞

2026-05-011
PRE
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
2023-12-204
OAAI
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
2023-06-275
OAAI
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

BRCA1或BRCA2致病变异携带者的身高,体重指数和体重增加与乳腺癌风险的关联: BRCA1和BRCA2队列联盟

2023-06-206
OAAI
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes

对2135富集的BRCA阴性乳腺癌中罕见的破坏性种系突变的分析排除了其他高影响易感基因

2022-12-018
OA
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
2022-11-0112
OAAI
UK recommendations for SDHA germline genetic testing and surveillance in clinical practice

英国对临床实践中SDHA种系基因检测和监测的建议

2022-03-0810
OAAI
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD
2022-01-016
OAAI
SDHC phaeochromocytoma and paraganglioma: A UK-wide case series
2021-09-2411
OA
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
2021-07-0137
OAAI
Prostate Cancer Risk by BRCA2 Genomic Regions
2020-10-017
OAAI